Capital International Investors Portfolio holdings
Capital International, established in 1968 as a division of the Los Angeles-based Capital Group, is a global investment management firm focused on delivering equity investment solutions for institutional and individual clients worldwide. Operating as part of one of the oldest and largest asset managers, founded in 1931, it leverages Capital Group’s signature research-driven, long-term investment philosophy, managing billions in assets through a multi-manager system that diversifies risk and enhances performance. Headquartered in Los Angeles with a presence across North America, Europe, and Asia, Capital International specializes in international and global equity strategies, often through mutual funds like those in the American Funds family. Known for its rigorous fundamental analysis and commitment to client outcomes, it plays a key role in Capital Group’s mission to provide consistent, superior returns in global markets.
Top Buys
| 1 |
SI
SIEMENS AKTIENGESELLSCHAFT ADS
SI
|
$143M |
| 2 |
Danaher
DHR
|
$98M |
| 3 |
Merck
MRK
|
$95M |
| 4 |
Automatic Data Processing
ADP
|
$94.2M |
| 5 |
Enbridge
ENB
|
$76.8M |
Top Sells
| 1 |
HSP
HOSPIRA INC
HSP
|
$124M |
| 2 |
NYX
NYSE EURONEXT INC
NYX
|
$113M |
| 3 |
Halliburton
HAL
|
$111M |
| 4 |
Petrobras
PBR
|
$106M |
| 5 |
RTX Corp
RTX
|
$101M |
Sector Composition
| 1 | Healthcare | 16.38% |
| 2 | Industrials | 12.52% |
| 3 | Consumer Discretionary | 11.4% |
| 4 | Technology | 10.71% |
| 5 | Financials | 10.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Gilead Sciences
GILD
$140B
| $634M | 2.71% | 10,087,700 -266,600 | -3% | -$16.8M |
|
2
Home Depot
HD
$405B
| $563M | 2.4% | 7,419,702 -323,000 | -4% | -$24.5M |
|
3
Texas Instruments
TXN
$184B
| $546M | 2.33% | 13,568,259 +1,400,900 | +12% | +$56.4M |
|
4
Microsoft
MSFT
$3.77T
| $531M | 2.27% | 15,929,798 +148,000 | +0.9% | +$4.93M |
|
5
Oracle
ORCL
$635B
| $477M | 2.04% | 14,384,000 +1,113,000 | +8% | +$36.9M |
|
6
Amgen
AMGN
$155B
| $471M | 2.01% | 4,209,748 -283,400 | -6% | -$31.7M |
|
7
DuPont de Nemours
DD
$32.2B
| $385M | 1.65% | 10,036,837 | – | – |
|
|
8
Merck
MRK
$210B
| $366M | 1.56% | 7,683,390 +1,995,300 | +35% | +$95M |
|
9
Bristol-Myers Squibb
BMY
$96B
| $346M | 1.48% | 7,469,500 | – | – |
|
|
10
RTX Corp
RTX
$212B
| $343M | 1.47% | 3,181,900 -940,100 | -23% | -$101M |
|
11
Amazon
AMZN
$2.44T
| $322M | 1.38% | 1,029,800 | – | – |
|
12
Chevron
CVX
$324B
| $298M | 1.27% | 2,452,700 -60,000 | -2% | -$7.29M |
|
13
Carnival Corp
CCL
$43.2B
| $289M | 1.24% | 8,861,600 +136,600 | +2% | +$4.46M |
|
14
ConocoPhillips
COP
$124B
| $277M | 1.18% | 3,978,360 | – | – |
|
15
AbbVie
ABBV
$372B
| $274M | 1.17% | 6,127,000 +710,000 | +13% | +$31.8M |
|
16
3M
MMM
$82.8B
| $265M | 1.13% | 2,221,000 | – | – |
|
17
Pfizer
PFE
$141B
| $264M | 1.13% | 9,178,851 | – | – |
|
18
Mondelez International
MDLZ
$79.5B
| $245M | 1.05% | 7,794,000 | – | – |
|
19
Emerson Electric
EMR
$74.3B
| $243M | 1.04% | 3,755,000 | – | – |
|
20
Waste Management
WM
$91.2B
| $240M | 1.02% | 5,815,300 +179,200 | +3% | +$7.39M |
|
21
Moody's
MCO
$91.4B
| $239M | 1.02% | 3,404,558 | – | – |
|
22
Apple
AAPL
$3.45T
| $239M | 1.02% | 501,000 -134,700 | -21% | -$64.2M |
|
23
Schlumberger
SLB
$55B
| $235M | 1% | 2,655,000 -387,000 | -13% | -$34.2M |
|
24
Air Products & Chemicals
APD
$65.5B
| $229M | 0.98% | 2,150,000 | – | – |
|
25
Booking.com
BKNG
$181B
| $225M | 0.96% | 223,000 | – | – |
|